Patent · US Active

Inhibitors of hepatitis C virus

US9617310B2 · kind B2 · utility

0Cited by
24References
4Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 14, 2014
Grant dateApr 11, 2017
Priority date
Expiry dateMay 16, 2034

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D498/22
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compounds of formula I:or pharmaceutically acceptable salts thereof, wherein the various substituents are defined herein, methods of using said compounds, and pharmaceutical compositions containing said compounds.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.